Moneycontrol PRO
Upcoming Webinar:Join us for 'The Future Techshot' on Sept 22, 10:30am to gain insights into role of tech in streamlining businesses. Register Now!
you are here: HomeNewsBusiness

Glenmark gets USFDA nod for generic Westcort cream

The product is a generic version of Sun Pharmaceutical Industries' Westcort Cream in the same strength, it added.

October 15, 2018 / 04:14 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Glenmark Pharmaceuticals said it has received final nod from the US health regulator for generic Hydrocortisone Valerate cream used for providing relief in inflammation and itching due to various skin conditions.

Glenmark Pharmaceuticals Inc has been granted final approval by the United States Food & Drug Administration (USFDA) for Hydrocortisone Valerate Cream USP, 0.2 percent, Glenmark said in a statement.

The product is a generic version of Sun Pharmaceutical Industries' Westcort Cream in the same strength, it added.

According to IQVIA sales data for the 12-month period ending August 2018, the Westcort Cream, 0.2 percent market achieved annual sales of around $17 million, Glenmark said.

The company's current portfolio consists of 139 products authorised for distribution in the US marketplace and 60 abbreviated new drug applications (ANDA's) pending approval with the USFDA, Glenmark said.

Close
Shares of Glenmark Pharmaceuticals were today trading at Rs 611.55 per scrip on BSE, up 1.78 percent from its previous close in late afternoon trade.
PTI
first published: Oct 15, 2018 04:00 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark